SZSE:300049 (China)
Â
Class A
Â¥
31.22
+1.31 (+4.38%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Inner Mongolia Furui Medical Science Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE100000KG1
Share Class Description:
SZSE:300049: Class ACompare
Compare
Traded in other countries / regions
300049.China IPO Date
2010-01-20Description
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.23 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.24 | |||||
| Interest Coverage | 277.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.93 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.7 | |||||
| 3-Year EBITDA Growth Rate | 18.3 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | 7.6 | |||||
| 3-Year Book Growth Rate | 4.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 59.39 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 31.15 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.52 | |||||
| 9-Day RSI | 47.28 | |||||
| 14-Day RSI | 45.35 | |||||
| 3-1 Month Momentum % | 14.12 | |||||
| 6-1 Month Momentum % | -24.3 | |||||
| 12-1 Month Momentum % | -29.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.88 | |||||
| Quick Ratio | 3.52 | |||||
| Cash Ratio | 1.61 | |||||
| Days Inventory | 119.44 | |||||
| Days Sales Outstanding | 123.06 | |||||
| Days Payable | 84.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.2 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.75 | |||||
| Operating Margin % | 22.17 | |||||
| Net Margin % | 9.83 | |||||
| FCF Margin % | 2.33 | |||||
| ROE % | 8.3 | |||||
| ROA % | 4.84 | |||||
| ROIC % | 12.61 | |||||
| 3-Year ROIIC % | 44.68 | |||||
| ROC (Joel Greenblatt) % | 34.69 | |||||
| ROCE % | 11.4 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 63.58 | |||||
| Forward PE Ratio | 29.45 | |||||
| PE Ratio without NRI | 61.82 | |||||
| Shiller PE Ratio | 84.38 | |||||
| Price-to-Owner-Earnings | 300.2 | |||||
| PEG Ratio | 4.15 | |||||
| PS Ratio | 6.24 | |||||
| PB Ratio | 5.18 | |||||
| Price-to-Tangible-Book | 9.18 | |||||
| Price-to-Free-Cash-Flow | 251.78 | |||||
| Price-to-Operating-Cash-Flow | 36.65 | |||||
| EV-to-EBIT | 28.45 | |||||
| EV-to-EBITDA | 28.45 | |||||
| EV-to-Revenue | 5.89 | |||||
| EV-to-FCF | 241.37 | |||||
| Price-to-GF-Value | 0.71 | |||||
| Price-to-Projected-FCF | 3.69 | |||||
| Price-to-DCF (Earnings Based) | 3.52 | |||||
| Price-to-DCF (FCF Based) | 18.36 | |||||
| Price-to-Median-PS-Value | 1.28 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.89 | |||||
| Price-to-Graham-Number | 5.02 | |||||
| Price-to-Net-Current-Asset-Value | 84.38 | |||||
| Earnings Yield (Greenblatt) % | 3.51 | |||||
| FCF Yield % | 0.37 | |||||
| Forward Rate of Return (Yacktman) % | 21.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inner Mongolia Furui Medical Science Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,326.594 | ||
| EPS (TTM) (Â¥) | 0.491 | ||
| Beta | -0.09 | ||
| 3-Year Sharpe Ratio | 0.69 | ||
| 3-Year Sortino Ratio | 1.22 | ||
| Volatility % | 33.08 | ||
| 14-Day RSI | 45.35 | ||
| 14-Day ATR (Â¥) | 1.708455 | ||
| 20-Day SMA (Â¥) | 32.5575 | ||
| 12-1 Month Momentum % | -29.26 | ||
| 52-Week Range (Â¥) | 26.61 - 56.77 | ||
| Shares Outstanding (Mil) | 266.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inner Mongolia Furui Medical Science Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inner Mongolia Furui Medical Science Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inner Mongolia Furui Medical Science Co Ltd Frequently Asked Questions
What is Inner Mongolia Furui Medical Science Co Ltd(SZSE:300049)'s stock price today?
The current price of SZSE:300049 is ¥31.22. The 52 week high of SZSE:300049 is ¥56.77 and 52 week low is ¥26.61.
When is next earnings date of Inner Mongolia Furui Medical Science Co Ltd(SZSE:300049)?
The next earnings date of Inner Mongolia Furui Medical Science Co Ltd(SZSE:300049) is .
Does Inner Mongolia Furui Medical Science Co Ltd(SZSE:300049) pay dividends? If so, how much?
Inner Mongolia Furui Medical Science Co Ltd(SZSE:300049) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers